Works matching IS 11087471 AND DT 2019 AND VI 32 AND IP 4


Results: 17
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers.

    Published in:
    Annals of Gastroenterology, 2019, v. 32, n. 4, p. 392, doi. 10.20524/aog.2019.0377
    By:
    • Tursi, Antonio;
    • Mocci, Giammarco;
    • Faggiani, Roberto;
    • Allegretta, Leonardo;
    • Valle, Nicola Della;
    • Forti, Giacomo;
    • Franceschi, Marilisa;
    • Ferronato, Antonio;
    • Gallina, Sara;
    • Larussa, Tiziana;
    • Luzza, Francesco;
    • Lorenzetti, Roberto;
    • Penna, Antonio;
    • Rodino, Stefano;
    • Sebkova, Ladislava;
    • Lauria, Angelo;
    • Piergallini, Simona;
    • Pranzo, Giuseppe;
    • Ricciardelli, Cristina;
    • Zampaletta, Costantino
    Publication type:
    Article
    10
    11
    12
    13
    14

    Rheumatologic manifestations of hepatic diseases.

    Published in:
    Annals of Gastroenterology, 2019, v. 32, n. 4, p. 352, doi. 10.20524/aog.2019.0386
    By:
    • Fernandes, Bruno;
    • Dias, Emanuel;
    • Mascarenhas-Saraiva, Miguel;
    • Bernardes, Miguel;
    • Costa, Lúcia;
    • Cardoso, Hélder;
    • Macedo, Guilherme
    Publication type:
    Article
    15
    16
    17

    Aiming towards hepatitis C virus elimination in Greece.

    Published in:
    Annals of Gastroenterology, 2019, v. 32, n. 4, p. 321, doi. 10.20524/aog.2019.0375
    By:
    • Papatheodoridis, George V.;
    • Goulis, John;
    • Sypsa, Vana;
    • Lionis, Christos;
    • Manolakopoulos, Spilios;
    • Elefsiniotis, Ioannis;
    • Anagnostou, Olga;
    • Tsoulas, Christos;
    • Hatzakis, Angelos;
    • Dalekos, George N.
    Publication type:
    Article